13
Participants
Start Date
April 9, 2019
Primary Completion Date
July 5, 2022
Study Completion Date
July 5, 2022
glycomacropeptide (GMP)
For each of the two baseline visits, women will consume a 300 calorie liquid breakfast meal tolerance test (MTT), eat a standard test lunch ad libitum with recording of food intake, and will then begin the low-dose GMP (25 g BID with meals) or high-dose GMP (25 g TID with meals) for 7 days. On day 7 of each GMP diet, women will come to the Clinical Research Unit (CRU) for a second breakfast MTT followed by lunch. All subjects will stop GMP products for 5-7 days (washout).
University of Wisconsin-Madison, Madison
University of Wisconsin, Madison
OTHER